These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1897672)
1. [State of the breasts in patients with hyperprolactinemia-induced amenorrhea and the effect of the treatment with parlodel]. Prilepskaia VN; Burdina LM; Egorova EB; Vaskakova LA; Kononova EF Akush Ginekol (Mosk); 1991 May; (5):47-50. PubMed ID: 1897672 [TBL] [Abstract][Full Text] [Related]
2. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy]. Ablanedo J; Canales ES Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433 [No Abstract] [Full Text] [Related]
3. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine. Murta EF; de Freitas MM; Velludo MA Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021 [TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine? Smith S J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137 [TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management. Ge QS; Xu L; Wang HL; Gu CX; Lin SQ; Xu YD; Yu KM; Xie YZ; Shi YF; Zang X Chin Med J (Engl); 1985 Aug; 98(8):543-50. PubMed ID: 3937678 [No Abstract] [Full Text] [Related]
8. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenetic aspects of structural changes in the breasts in benign hyperplastic uterine diseases in patients of reproductive age]. Uvarova EV; Burdina LM; Volobuev AI Akush Ginekol (Mosk); 1990 Oct; (10):44-8. PubMed ID: 2288361 [No Abstract] [Full Text] [Related]
10. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case]. Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885 [TBL] [Abstract][Full Text] [Related]
11. Amenorrhea, galactorrhea, and hyperprolactinemia. Magyar DM J Am Osteopath Assoc; 1985 Jun; 85(6):375-80. PubMed ID: 3905728 [No Abstract] [Full Text] [Related]
12. Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia. Weingrill CO; Mussio W; Moraes CR; Portes E; Castro RC; Lengyel AM Fertil Steril; 1992 Feb; 57(2):331-5. PubMed ID: 1735484 [TBL] [Abstract][Full Text] [Related]
14. Progress in the management of hyperprolactinemia. Serri O N Engl J Med; 1994 Oct; 331(14):942-4. PubMed ID: 7915825 [No Abstract] [Full Text] [Related]
15. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia. Bolanowski M; Milewicz A; Bohdanowicz-Pawlak A; Bednarek-Tupikowska G; Jedrzejak JA; Lancranjan I Endokrynol Pol; 1993; 44(4):467-76. PubMed ID: 8055815 [TBL] [Abstract][Full Text] [Related]
16. [Effect of parlodel and thyroliberin on prolactin secretion in patients with fibrocystic mastopathy]. Sturia NT Probl Endokrinol (Mosk); 1983; 29(2):21-4. PubMed ID: 6406998 [TBL] [Abstract][Full Text] [Related]
17. [Dopamine in the pathogenesis of normogonadotropic amenorrhea]. Iumatov TD; Isakov AV; Potin VV; Svechnikova FA Probl Endokrinol (Mosk); 1986; 32(4):32-6. PubMed ID: 3093998 [TBL] [Abstract][Full Text] [Related]